文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

2024年河南省人群百日咳血清流行病学研究

[Seroepidemiological study of pertussis among the population of Henan Province in 2024].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2026-01-01

2024年在河南省16个省辖市31个乡镇(街道)纳入9 233名常住人口开展横断面调查,采用ELISA检测PT-IgG和FHA-IgG。PT-IgG和FHA-IgG总阳性率分别为18.61%和45.42%,保护率为14.52%;学龄儿童为高发病人群,青少年及成人感染被低估。

要点

  • PT-IgG总阳性率18.61%,FHA-IgG总阳性率45.42%,保护率仅14.52%
  • PT-IgG阳性率随年龄下降,FHA-IgG阳性率随年龄上升
  • 学龄儿童为高发病人群,青少年及成人感染被低估

核心结论

  • 2024年河南省人群百日咳PT-IgG、FHA-IgG水平随年龄波动明显,保护率较低。
  • 学龄儿童为百日咳高发病人群,青少年及成人感染被低估。

研究设计与样本

  • 2024年在河南省16个省辖市选取31个乡镇(街道)开展横断面调查,纳入9 233名常住人口。
  • 采用酶联免疫吸附试验(ELISA)检测PT-IgG和FHA-IgG,分析不同年龄和免疫史人群的抗体阳性率(≥20 IU/ml)、保护率(PT-IgG和FHA-IgG浓度同时≥20 IU/ml)及浓度差异。
  • 应用限制性立方样条(RCS)拟合二元logistic回归模型研究末剂免疫后抗体水平随时间的变化。
  • 通过中国疾病预防控制信息系统统计2024年河南省百日咳报告病例,以PT-IgG≥40 IU/ml估算人群感染率。

主要发现

  • 9 233名研究对象PT-IgG和FHA-IgG总阳性率分别为18.61%和45.42%,浓度M(Q1,Q3)分别为5.46(1.14,15.02)IU/ml和16.70(5.11,40.88)IU/ml,保护率为14.52%。
  • PT-IgG和FHA-IgG阳性率随年龄增长分别呈下降和上升趋势(χ2趋势分别为16.79和580.72,均P<0.001)。
  • 百日咳疫苗末剂免疫后不同时间儿童的PT-IgG阳性率、FHA-IgG阳性率和保护率差异均有统计学意义(χ2分别为119.97、421.35和100.27,均P<0.001)。
  • RCS分析显示PT-IgG和FHA-IgG抗体水平与末剂免疫后时间均存在非线性关联(P总体<0.001,P非线性<0.001)。
  • 2024年河南省百日咳报告发病率为23.09/10万;<1、5~<6、6~<7、7~<10岁组病例构成比分别为14.02%、13.24%、15.10%和22.80%;≥3岁人群估算感染率为9 705.47/10万,5~<6、6~<7和7~<10岁人群感染率均高于11 000/10万,15~<20岁青少年和≥20岁成人估算感染率分别为10 351.27/10万和8 672.82/10万。

关键数值与推荐

  • 抗体阳性率判定标准:抗体浓度≥20 IU/ml。
  • 保护率判定标准:PT-IgG和FHA-IgG抗体浓度同时≥20 IU/ml。
  • 感染率估算标准:PT-IgG≥40 IU/ml。

临床怎么用

  • 应关注学龄儿童百日咳高发风险,并重视青少年及成人百日咳感染的识别与报告。
  • 人群百日咳保护率较低,需结合年龄和末剂免疫后时间评估免疫保护状况。
  • 可利用PT-IgG≥40 IU/ml的血清学标准辅助估算人群百日咳感染率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To analyze the variation characteristics of pertussis toxin IgG (PT-IgG) and filamentous hemagglutinin IgG (FHA-IgG), as well as the immune protection and infection status of pertussis in Henan Province. Methods: A cross-sectional survey was conducted in 31 townships (streets) selected from 16 prefecture-level cities in Henan Province in 2024. A total of 9 233 permanent residents were enrolled in the study. Serum levels of PT-IgG and FHA-IgG were detected by enzyme-linked immunosorbent assay (ELISA). Antibody positivity rates (≥20 IU/ml), protection rates (both PT-IgG and FHA-IgG concentrations ≥20 IU/ml), and concentration differences were analyzed among populations with different age groups and immunization histories. A binary logistic regression model with restricted cubic splines (RCS) was used to investigate changes in PT-IgG and FHA-IgG antibody levels over time since the last vaccination dose. The reported cases of pertussis in Henan Province in 2024 were collected via the China Information System for Disease Control and Prevention, and the pertussis infection rate was estimated based on the PT-IgG level≥40 IU/ml. Results: Among the 9 233 participants, the overall positivity rates for PT-IgG and FHA-IgG were 18.61% and 45.42%, respectively, with the median concentrations being 5.46 (1.14, 15.02) IU/ml and 16.70 (5.11, 40.88) IU/ml, respectively, and the protection rate was 14.52%. The positive rate of PT-IgG showed a decreasing trend with age, while that of FHA-IgG showed an increasing trend (χ2 for trend=16.79, 580.72, both P<0.001). Significant differences were observed in PT-IgG positivity rates, FHA-IgG positivity rates, and protection rates among children at different time intervals after the last dose of pertussis vaccine (χ2=119.97, 421.35, and 100.27; all P<0.001). Nonlinear relationships were found between the odds ratios (OR) of PT-IgG/FHA-IgG antibody levels and the time after the last vaccination dose (Poverall<0.001, Pnonlinear<0.001). In 2024, the reported incidence rate of pertussis was 23.09/100 000. The age groups of <1 year, 5-<6 years, 6-<7 years, and 7-<10 years accounted for a relatively high proportion of cases, at 14.02%, 13.24%, 15.10%, and 22.80%, respectively. The estimated infection rate was 9 705.47 per 100 000 among people aged ≥3 years, and the infection rates in the 5-<6, 6-<7, and 7-<10-year age groups were all higher than 11 000 per 100 000. For adolescents aged 15-<20 years and adults aged ≥20 years, the estimated infection rates were 10 351.27 per 100 000 and 8 672.82 per 100 000, respectively. Conclusion: In 2024, the levels of pertussis PT-IgG and FHA-IgG antibodies in the population of Henan Province fluctuate significantly with age, and the protection rate is relatively low. School-age children constitute the high-risk group for pertussis morbidity, and the infection in adolescents and adults is underestimated. 目的: 分析河南省人群抗百日咳毒素IgG抗体(PT-IgG)与抗丝状血凝素IgG抗体(FHA-IgG)变化特征、免疫保护及感染状况。 方法: 采用横断面研究方法,于2024年在河南省16个省辖市选取31个乡镇(街道),共将9 233名常住人口纳入研究,采用酶联免疫吸附试验检测PT-IgG和FHA-IgG,分析不同年龄、免疫史人群抗体阳性率(抗体浓度≥20 IU/ml)、保护率(PT-IgG和FHA-IgG抗体浓度同时≥20 IU/ml)和抗体浓度差异,应用限制性立方样条(RCS)拟合二元logistic回归模型研究末剂免疫后PT-IgG和FHA-IgG抗体水平随时间的变化情况。通过中国疾病预防控制信息系统统计2024年河南省百日咳报告病例情况;以PT-IgG≥40 IU/ml估算人群百日咳感染率。 结果: 9 233名研究对象的PT-IgG和FHA-IgG总阳性率分别为18.61%和45.42%,浓度M(Q1,Q3)分别为5.46(1.14,15.02)IU/ml和16.70(5.11,40.88)IU/ml,保护率为14.52%。PT-IgG和FHA-IgG阳性率随着年龄增长分别呈下降和上升趋势(χ2趋势分别为16.79和580.72,均P<0.001)。百日咳疫苗末剂免疫后不同时间儿童的PT-IgG阳性率、FHA-IgG阳性率和保护率的差异均有统计学意义(χ2分别为119.97、421.35和100.27,均P<0.001)。RCS分析结果显示,PT-IgG和FHA-IgG抗体水平与末剂免疫后时间之间均存在非线性关联(P总体<0.001,P非线性<0.001)。2024年河南省百日咳报告发病率为23.09/10万,<1、5~<6、6~<7、7~<10岁组病例构成比较高,分别为14.02%、13.24%、15.10%和22.80%;≥3岁人群的估算感染率为9 705.47/10万,5~<6、6~<7和7~<10岁人群的感染率均高于11 000/10万,15~<20岁青少年和≥20岁成人的感染率分别为10 351.27/10万和8 672.82/10万。 结论: 2024年河南省人群百日咳PT-IgG、FHA-IgG水平随年龄波动明显、保护率较低;学龄儿童为高发病人群,青少年及成人感染被低估。.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu Q, Tang YT, Kong JN, et al. [Seroepidemiological study of pertussis among the population of Henan Province in 2024]. Zhonghua Yu Fang Yi Xue Za Zhi. 2026. PMID: 42331530. doi:10.3760/cma.j.cn112150-20250805-00756

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。